Prolotherapy injects a mild irritant, usually hyperosmolar dextrose, into ligament and tendon insertions to trigger controlled inflammation and new collagen growth. It is one of the better-evidenced regenerative injections: a systematic review found moderate evidence for safety and symptom control in knee osteoarthritis, with positive trials in tendinopathy and sacroiliac dysfunction. Serious adverse events are essentially absent from the literature. Caveats: it is rarely covered by insurance, and the evidence is still small trials rather than large definitive ones.
Summary drafted from this entry’s sources; editorial review pending.
01Key questions
Does prolotherapy work?
Reasonably supported for a few indications. A systematic review found moderate evidence for safety and symptom control in knee osteoarthritis, multiple trials show benefit in tennis elbow and Achilles tendinopathy, and sacroiliac dysfunction has strong reported efficacy. Benefits persisted at 12-month follow-up in some studies. Evidence is thinner for TMJ, whiplash and plantar fasciitis.1
How does prolotherapy work?
Hyperosmolar dextrose at the ligament or tendon insertion causes local osmotic shock and controlled inflammation, recruiting fibroblasts that deposit new collagen over the following weeks. The underlying theory is that weak, poorly vascularized ligaments cause joint instability and chronic pain, and restarting the healing cascade strengthens them.
Is prolotherapy safe?
The safety record is unusually good: no deaths or permanent injuries are reported in the literature, and the usual cost is a few days of soreness and bruising. Contraindications are active infection, bleeding disorder, pregnancy and local malignancy.
What would change this rating?
Larger placebo-controlled trials with standardized technique across the claimed indications; much of today's evidence is small trials and narrative reviews. Cost is the practical barrier: roughly $200-800 per session, usually out of pocket.
Core thesis: Prolotherapy (proliferative therapy) is a regenerative injection technique that introduces a mild irritant solution — typically dextrose — into painful ligament, tendon, or joint sites. This triggers a controlled inflammatory healing response, stimulating new tissue growth and strengthening weakened connective tissue. It is one of the oldest, safest, and most evidence-supported regenerative techniques.
02Mechanism of Action
The Healing Cascade Reactivation
- Injection of hyperosmolar dextrose (typically 12.5-25%) into ligament/tendon insertion or joint
- Local osmotic shock → controlled inflammation
- Chemotaxis: Neutrophils, macrophages, and fibroblasts recruited to the area
- Fibroblast activation → new collagen deposition
- Neovascularization → improved blood supply to poorly vascularized tissue
- Tissue strengthening over 4-8 weeks as new collagen matures and cross-links
Why It Works: The Problem with Connective Tissue
- Ligaments and tendons have poor blood supply — they don't heal well on their own
- After injury, initial healing often produces weak, disorganized scar tissue
- This weak tissue leads to joint instability → chronic pain, muscle spasm, and degeneration
- Prolotherapy restarts the healing cascade to produce stronger, organized collagen
The "Loose Ligament" Theory
- Originated by George Hackett, MD (1950s): Weak or lax ligaments cause joint instability
- Instability → chronic muscle spasm → referred pain patterns
- By strengthening ligaments, prolotherapy addresses the root cause rather than masking pain
03Types of Prolotherapy
Dextrose Prolotherapy (Standard)
- Solution: 12.5-25% dextrose in local anesthetic
- Most common and best-studied form
- Safe, inexpensive, widely available
Cellular Prolotherapy
- Adds PRP or stem cells to the dextrose solution
- Combines the proliferative stimulus with biological growth factors
- More expensive but potentially more effective for advanced degeneration
Neural Prolotherapy (Perineural Injection Treatment / PIT)
- Developed by John Lyftogt, MD
- Solution: 5% dextrose injected subcutaneously near superficial nerves
- Targets neurogenic inflammation — TRPV1 receptor-mediated pain
- Particularly effective for nerve-related pain (neuropathy, complex regional pain syndrome)
Hackett-Hemwall Prolotherapy
- Classical technique: multiple injection points along ligament/tendon insertions
- Typically 3-6 treatment sessions at 4-6 week intervals
- Named after pioneers George Hackett and Gustav Hemwall
04Clinical Evidence
Knee Osteoarthritis (Strong Evidence)
- PMID 28334196: Systematic review found "moderate evidence that prolotherapy is safe and can help achieve significant symptomatic control in OA"
- Multiple RCTs show improvement in pain, function, and range of motion
- Compared favorably to exercise therapy, NSAIDs, and cortisone injections
- Benefits sustained at 12-month follow-up in some studies
Tendinopathy (Moderate-Strong)
- Achilles tendinopathy: Significant improvement in pain and function
- Lateral epicondylitis (tennis elbow): Multiple positive trials
- Rotator cuff tendinopathy: Growing evidence of efficacy
Low Back Pain (Moderate)
- Sacroiliac joint dysfunction: Strong evidence for prolotherapy efficacy
- Ligamentous low back pain: Multiple studies show benefit
- Particularly effective when instability/laxity is the underlying issue
Other Conditions
- TMJ disorders: Case series and small trials show benefit
- Neck pain/whiplash: Emerging evidence
- Joint hypermobility/Ehlers-Danlos: Anecdotal but promising
- Plantar fasciitis: Moderate evidence
05Uses
What to Expect
- 24-72 hours post: Temporary increase in soreness/stiffness (the inflammatory response)
- Weeks 1-3: Gradual improvement as new tissue forms
- By week 4-6: Significant improvement typically apparent
- Cumulative: Each session builds on previous tissue strengthening
Adjunctive Measures
- Avoid NSAIDs for 2-4 weeks post-treatment (NSAIDs suppress the intended inflammatory response)
- Gentle movement encouraged (walking, ROM exercises)
- Avoid aggressive stretching of treated areas for 2-3 weeks
- Physical therapy often combined for optimal results
06Safety Profile
| Aspect | Assessment |
|---|---|
| Serious adverse events | Extremely rare — no deaths or permanent injuries reported in literature |
| Common side effects | Temporary soreness, bruising, stiffness (2-5 days) |
| Allergic reactions | Rare — dextrose is a naturally occurring sugar |
| Infection risk | Minimal with sterile technique (<1:10,000) |
| Contraindications | Active infection, bleeding disorder, pregnancy, local malignancy |
| Cost | $200-800 per session (often not covered by insurance) |
Swipe table →
07Connections
08Sources
- Sarbetter R et al. (2016). "Prolotherapy in Knee Osteoarthritis." PMID 28334196PubMed 28334196
- Hauser RA et al. (2022). "Prolotherapy: A Narrative Review of Mechanisms." PMID 36410881PubMed 36410881
- Rabago D et al. (2025). "Prolotherapy as Regenerative Treatment." PMC12472176PMC12472176
09Entry history
Latest content update.
Heretic informs and never prescribes. Where amounts appear, they describe what published studies used. Talk to a qualified clinician before acting on anything here.